4-methylpyrazole protects against acetaminophen-induced acute kidney injury.

[1]  H. Jaeschke,et al.  A mitochondrial journey through acetaminophen hepatotoxicity. , 2020, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[2]  A. Scalzo,et al.  Use of fomepizole as an adjunct in the treatment of acetaminophen overdose: a case series , 2020 .

[3]  H. Jaeschke,et al.  The Effect of 4-Methylpyrazole on Oxidative Metabolism of Acetaminophen in Human Volunteers , 2019, Journal of Medical Toxicology.

[4]  M. Czaja,et al.  Acetaminophen Intoxication Rapidly Induces Apoptosis of Intestinal Crypt Stem Cells and Enhances Intestinal Permeability , 2019, Hepatology communications.

[5]  P. Murray,et al.  Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation Study , 2019, American Journal of Nephrology.

[6]  M. Saleem,et al.  A Rare Case of Acetaminophen Toxicity Leading to Severe Kidney Injury , 2019, Cureus.

[7]  Aaron B. Skolnik,et al.  The Relationship Between Circulating Acetaminophen-Protein Adduct Concentrations and Alanine Aminotransferase Activities in Patients With and Without Acetaminophen Overdose and Toxicity , 2019, Journal of Medical Toxicology.

[8]  M. Manns,et al.  Outcomes of renal dysfunction in patients with acute liver failure , 2019, United European gastroenterology journal.

[9]  H. Jaeschke,et al.  Delayed Treatment With 4-Methylpyrazole Protects Against Acetaminophen Hepatotoxicity in Mice by Inhibition of c-Jun n-Terminal Kinase. , 2019, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  H. Jaeschke,et al.  Acetaminophen Hepatotoxicity , 2019, Seminars in Liver Disease.

[11]  L. Jafri,et al.  The utility of neutrophil gelatinase-associated Lipocalin (NGAL) as a marker of acute kidney injury (AKI) in critically ill patients , 2019, Biomarker Research.

[12]  S. Curry,et al.  Evaluation and treatment of acetaminophen toxicity. , 2019, Advances in pharmacology.

[13]  J. Kellum,et al.  Global epidemiology and outcomes of acute kidney injury , 2018, Nature Reviews Nephrology.

[14]  B. Turna,et al.  Inter-individual and inter-organ variability in the bioactivation of paracetamol by human liver and kidney tissues. , 2018, Environmental toxicology and pharmacology.

[15]  H. Jaeschke,et al.  4-Methylpyrazole protects against acetaminophen hepatotoxicity in mice and in primary human hepatocytes , 2018, Human & experimental toxicology.

[16]  Mitchell R. McGill,et al.  Extrahepatic toxicity of acetaminophen: critical evaluation of the evidence and proposed mechanisms , 2017, Journal of clinical and translational research.

[17]  M. Kutner,et al.  Acetaminophen-Induced Hepatotoxicity: a Comprehensive Update , 2016, Journal of clinical and translational hepatology.

[18]  Mitchell R. McGill,et al.  A direct comparison of methods used to measure oxidized glutathione in biological samples: 2-vinylpyridine and N-ethylmaleimide , 2015, Toxicology mechanisms and methods.

[19]  J. Lai,et al.  Kidney Failure and Liver Allocation: Current Practices and Potential Improvements. , 2015, Advances in chronic kidney disease.

[20]  Thomas M. Leventhal,et al.  What a Nephrologist Needs to Know About Acute Liver Failure. , 2015, Advances in chronic kidney disease.

[21]  H. Jaeschke.  Acetaminophen: Dose-Dependent Drug Hepatotoxicity and Acute Liver Failure in Patients , 2015, Digestive Diseases.

[22]  William M. Lee,et al.  Risk factors and outcomes of acute kidney injury in patients with acute liver failure. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[23]  Mitchell R. McGill,et al.  Lower susceptibility of female mice to acetaminophen hepatotoxicity: Role of mitochondrial glutathione, oxidant stress and c-jun N-terminal kinase. , 2014, Toxicology and applied pharmacology.

[24]  B. Bhushan,et al.  Pro-regenerative signaling after acetaminophen-induced acute liver injury in mice identified using a novel incremental dose model. , 2014, The American journal of pathology.

[25]  Mitchell R. McGill,et al.  Mechanisms of acetaminophen-induced cell death in primary human hepatocytes. , 2014, Toxicology and applied pharmacology.

[26]  P. Hayes,et al.  Acute kidney injury in acute liver failure: a review , 2013, Expert review of gastroenterology & hepatology.

[27]  J. Brouard,et al.  Insuffisance rénale secondaire à une intoxication au paracétamol : à propos de 3 cas , 2013 .

[28]  Mitchell R. McGill,et al.  Metabolism and Disposition of Acetaminophen: Recent Advances in Relation to Hepatotoxicity and Diagnosis , 2013, Pharmaceutical Research.

[29]  Hartmut Jaeschke,et al.  Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. , 2012, Toxicology and applied pharmacology.

[30]  Michael J Hodgman,et al.  A review of acetaminophen poisoning. , 2012, Critical care clinics.

[31]  Hartmut Jaeschke,et al.  The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. , 2012, The Journal of clinical investigation.

[32]  B. Hendry,et al.  Acute kidney injury in patients admitted to a liver intensive therapy unit with paracetamol-induced hepatotoxicity. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  Y. Masubuchi,et al.  Sex difference in susceptibility to acetaminophen hepatotoxicity is reversed by buthionine sulfoximine. , 2011, Toxicology.

[34]  K. Bek,et al.  A case of acetaminophen (paracetamol) causing renal failure without liver damage in a child and review of literature , 2010, Renal failure.

[35]  J. Brent.  Fomepizole for ethylene glycol and methanol poisoning. , 2009, The New England journal of medicine.

[36]  J. Neuberger,et al.  Outcomes of liver transplantation for paracetamol (acetaminophen)‐induced hepatic failure , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[37]  T. Rimmelé,et al.  Insuffisance rénale aiguë lors d’intoxication à l’acétaminophène: à propos de trois cas , 2009 .

[38]  P. Hayes,et al.  The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure , 2008, Gut.

[39]  K. Heard,et al.  Acetylcysteine for acetaminophen poisoning. , 2008, The New England journal of medicine.

[40]  D. Waxman,et al.  Determination of CYP2B6 component of 7-ethoxy-4-trifluoromethylcoumarin O-deethylation activity in human liver microsomes. , 2006, Methods in molecular biology.

[41]  H. Jaeschke,et al.  Peroxynitrite-Induced Mitochondrial and Endonuclease-Mediated Nuclear DNA Damage in Acetaminophen Hepatotoxicity , 2005, Journal of Pharmacology and Experimental Therapeutics.

[42]  Steven D. Cohen,et al.  Contribution of acetaminophen-cysteine to acetaminophen nephrotoxicity in CD-1 mice: I. Enhancement of acetaminophen nephrotoxicity by acetaminophen-cysteine. , 2005, Toxicology and applied pharmacology.

[43]  Steven D. Cohen,et al.  Standard of care may not protect against acetaminophen-induced nephrotoxicity. , 2004, Basic & clinical pharmacology & toxicology.

[44]  D. Ng,et al.  Hepatotoxicity and persistent renal insufficiency after repeated supratherapeutic paracetamol ingestion in a Chinese boy. , 2004, Hong Kong medical journal = Xianggang yi xue za zhi.

[45]  J. Manautou,et al.  Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[46]  E. Hazai,et al.  Reduction of toxic metabolite formation of acetaminophen. , 2002, Biochemical and biophysical research communications.

[47]  M. Shannon,et al.  Nephrotoxicity After Acute Severe Acetaminophen Poisoning in Adolescents , 2001, Journal of toxicology. Clinical toxicology.

[48]  L. Lash,et al.  Expression of glutathione-dependent enzymes and cytochrome P450s in freshly isolated and primary cultures of proximal tubular cells from human kidney. , 2000, The Journal of pharmacology and experimental therapeutics.

[49]  D. Eaton,et al.  Role of CYP1A2 in the hepatotoxicity of acetaminophen: investigations using Cyp1a2 null mice. , 1998, Toxicology and applied pharmacology.

[50]  D. Waxman,et al.  Determination of the CYP2B6 component of 7-ethoxy-4-trifluoromethylcoumarin O-deethylation activity in human liver microsomes. , 1998, Methods in molecular biology.

[51]  B. Materson,et al.  Acetaminophen‐Related Acute Renal Failure without Fulminant Liver Failure , 1997, Pharmacotherapy.

[52]  P. Blakely,et al.  Acute renal failure due to acetaminophen ingestion: a case report and review of the literature. , 1995, Journal of the American Society of Nephrology : JASN.

[53]  Steven D. Cohen,et al.  Immunohistochemical localization of acetaminophen in target tissues of the CD-1 mouse: correspondence of covalent binding with toxicity. , 1995, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[54]  Steven D. Cohen,et al.  Gender-related differences in susceptibility to acetaminophen-induced protein arylation and nephrotoxicity in the CD-1 mouse. , 1995, Toxicology and applied pharmacology.

[55]  Steven D. Cohen,et al.  Acetaminophen nephrotoxicity in CD-1 mice. I. Evidence of a role for in situ activation in selective covalent binding and toxicity. , 1994, Toxicology and applied pharmacology.

[56]  N. Ballatori,et al.  Glutathione conjugation and conversion to mercapturic acids can occur as an intrahepatic process. , 1994, Journal of toxicology and environmental health.

[57]  J. Buters,et al.  A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man. Direct fluorescence monitoring of the deethylation of 7-ethoxy-4-trifluoromethylcoumarin. , 1993, Biochemical pharmacology.

[58]  A. Jones,et al.  Paracetamol poisoning and the kidney , 1993, Journal of clinical pharmacy and therapeutics.

[59]  S. Emeighhart.  Evidence against deacetylation and for cytochrome P450-mediated activation in acetaminophen-induced nephrotoxicity in the CD-1 mouse. , 1991 .

[60]  S. D. Cohen,et al.  Evidence against deacetylation and for cytochrome P450-mediated activation in acetaminophen-induced nephrotoxicity in the CD-1 mouse. , 1991, Toxicology and applied pharmacology.

[61]  A. Davenport,et al.  Paracetamol (acetaminophen) poisoning resulting in acute renal failure without hepatic coma. , 1988, Nephron.

[62]  M. Aurell,et al.  Acute renal failure after analgesic drugs including paracetamol (acetaminophen). , 1988, Nephron.

[63]  Steven D. Cohen,et al.  Extrahepatic Lesions Induced by Acetaminophen in the Mouse , 1987, Toxicologic pathology.

[64]  W. Weber,et al.  Biochemical characterization of genetically variant aromatic amine N-acetyltransferases in A/J and C57BL/6J mice. , 1982, The Journal of biological chemistry.

[65]  D. Kerr,et al.  Paracetamol-induced acute renal failure in the absence of fulminant liver damage. , 1982, British medical journal.

[66]  W. H. Jeffery,et al.  Acute renal failure after acetaminophen overdose: report of two cases. , 1981, American journal of hospital pharmacy.

[67]  J. Kleinman,et al.  Acute renal failure associated with acetaminophen ingestion: report of a case and review of the literature. , 1980, Clinical nephrology.

[68]  J. Critchley,et al.  Intravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoning. , 1979, British medical journal.

[69]  J. Critchley,et al.  Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. , 1979, British medical journal.